Eurofins Forensics Benelux consists of laboratories located in both Belgium (Bruges) and The Netherlands (Maastricht/Amsterdam). As a Forensic Service Provider, Eurofins Forensic Benelux works in a highly regulated environment and must maintain and evidence high standards continuously. At present, the laboratories hold accreditation to ISO/IEC 17025:2017 and work in compliance with ISO/IEC 27001:2022. Due to the nature of the work, all laboratories handle sensitive, special category data on a daily basis and therefore management and protection of this information is critical.
Internship overview
This internship will provide a Dutch/Belgian student with in‑depth, practical experience in data privacy management, with a strong focus on Data Protection Impact Assessments (DPIAs) and the sustainable embedding of privacy risk management within the organization.
The intern will be actively involved in assessing privacy risks related to personal data processing activities, particularly in contexts involving special categories of data and criminal or law‑enforcement‑related data. The internship aligns theoretical knowledge of EU, Belgian and Dutch privacy legislation with real‑world governance, operational processes, and compliance requirements.
The internship is learning‑oriented and does not require a dedicated end project, though a formal assignment or report can be arranged if required by the educational institution.
Objective
The primary objective of the internship is to enable the student to develop practical competency in conducting DPIAs, managing privacy risks and assisting with identified improvement actions in a sustainable manner.
This will include:
The intern will receive structured supervision and regular feedback. If required by the educational institution, learning objectives, competencies, and assessment criteria can be formally aligned and documented.

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories.
Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing.
Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.